• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Spred2 抑制 TGF-β1 诱导的尿激酶型纤溶酶原激活物表达、细胞迁移和上皮间质转化。

Spred2 inhibits TGF-beta1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition.

机构信息

Cellular Biology Laboratory, Nutrition and Food Technology Institute, INTA, Universidad de Chile, Chile.

出版信息

Int J Cancer. 2010 Jul 1;127(1):77-85. doi: 10.1002/ijc.25045.

DOI:10.1002/ijc.25045
PMID:19908229
Abstract

TGF-beta1 is a potent inductor of malignance in cancer cells. TGF-beta1 stimulates the expression of extracellular matrix degrading proteases, cell migration and it is also involved in the epithelial-mesenchymal transition (EMT). In the present work, we analyzed the role of Spred2 in the urokinase-type plasminogen activator (uPA) stimulation, EMT and cell migration by TGF-beta1. We found that both the expression of mRNA and the protein level of Spred2 were lower in transformed keratinocytes PDV compared with immortalized keratinocytes MCA-3D. The transient ectopic expression of Spred2 in PDV cells inhibited the TGF-beta1-transactivated SRE-Luc reporter which is related with the ERK1,2 signal. The stable ectopic expression of Spred2 in PDV cells (SP cells) led to the loss of ERK 1,2 activation by TGF-beta1, although Smad2 activation was not affected, and the knockdown of Spred2 enhanced the activation of ERK1,2 signal by TGF-beta1. The increment of uPA expression induced by TGF-beta1 was suppressed in SP cells. In contrast, the stimulus on PAI-1 expression was not affected and comparable to parental PDV cells. SP cells under TGF-beta1 treatment were unable to display the EMT, since the overexpression of Spred2 abolished the TGF-beta1-induced disruption of the E-cadherin cell to cell interactions, reorganization of the actin cytoskeleton and upregulation of the mesenchymal marker vimentin. Finally, SP cells could not respond to the TGF-beta1 stimulus on cell migration. Taken together, the data in the present study suggests that Spred2 is a regulator of TGF-beta1-induced malignance in transformed keratinocytes.

摘要

TGF-β1 是癌细胞恶性转化的有效诱导剂。TGF-β1 可刺激细胞外基质降解蛋白酶的表达、细胞迁移,并且参与上皮-间充质转化(EMT)。在本研究中,我们分析了 Spred2 在尿激酶型纤溶酶原激活物(uPA)刺激、EMT 和 TGF-β1 诱导的细胞迁移中的作用。我们发现,与永生化角质细胞 MCA-3D 相比,转化角质细胞 PDV 中 Spred2 的 mRNA 表达和蛋白水平均降低。瞬时过表达 Spred2 可抑制与 ERK1、2 信号相关的 TGF-β1 转激活 SRE-Luc 报告基因。Spred2 在 PDV 细胞中的稳定过表达(SP 细胞)导致 TGF-β1 引起的 ERK1、2 激活丧失,尽管 Smad2 激活不受影响,而 Spred2 的敲低增强了 TGF-β1 对 ERK1、2 信号的激活。TGF-β1 诱导的 uPA 表达增加在 SP 细胞中受到抑制。相比之下,PAI-1 表达的刺激不受影响,与亲本 PDV 细胞相当。在 TGF-β1 处理下,SP 细胞无法显示 EMT,因为 Spred2 的过表达消除了 TGF-β1 诱导的 E-钙粘蛋白细胞间相互作用的破坏、肌动蛋白细胞骨架的重排和间充质标志物波形蛋白的上调。最后,SP 细胞无法对 TGF-β1 刺激的细胞迁移作出反应。总之,本研究的数据表明,Spred2 是转化角质细胞中 TGF-β1 诱导恶性转化的调节剂。

相似文献

1
Spred2 inhibits TGF-beta1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition.Spred2 抑制 TGF-β1 诱导的尿激酶型纤溶酶原激活物表达、细胞迁移和上皮间质转化。
Int J Cancer. 2010 Jul 1;127(1):77-85. doi: 10.1002/ijc.25045.
2
SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.SMAD3 对于转化生长因子-β1 诱导的尿激酶型纤溶酶原激活物表达和转化角质细胞迁移是必不可少的。
Eur J Cancer. 2012 Jul;48(10):1550-7. doi: 10.1016/j.ejca.2011.06.043. Epub 2011 Jul 26.
3
SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes.SKIP 对于 TGF-β1 诱导的转化角质细胞上皮间质转化和迁移是必需的。
FEBS Lett. 2010 Nov 19;584(22):4586-92. doi: 10.1016/j.febslet.2010.10.020. Epub 2010 Oct 19.
4
Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.尿激酶的表达及结合活性与转化生长因子β1诱导的小鼠表皮角质形成细胞迁移和侵袭表型相关。
J Cell Biochem. 1999 Jul 1;74(1):61-73.
5
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.碱性成纤维细胞生长因子-2在上皮-间质转化中的作用。
Kidney Int. 2002 May;61(5):1714-28. doi: 10.1046/j.1523-1755.2002.00333.x.
6
Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.在含有Ras癌基因的转化角质形成细胞中阻断Smad4会导致与向未分化癌进展相关的Ras依赖性Erk信号通路过度激活。
Oncogene. 2000 Aug 24;19(36):4134-45. doi: 10.1038/sj.onc.1203764.
7
ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion.ROS-NFkappaB 介导 TGF-beta1 诱导的尿激酶型纤溶酶原激活物、基质金属蛋白酶-9 的表达和细胞侵袭。
Mol Cell Biochem. 2010 Jul;340(1-2):195-202. doi: 10.1007/s11010-010-0418-5. Epub 2010 Mar 5.
8
Ganglioside GM3 participates in the TGF-β1-induced epithelial-mesenchymal transition of human lens epithelial cells.神经节苷脂 GM3 参与 TGF-β1 诱导的人晶状体上皮细胞上皮-间充质转化。
Biochem J. 2013 Jan 1;449(1):241-51. doi: 10.1042/BJ20120189.
9
[Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].Smad7对转化生长因子-β1诱导的肺泡上皮细胞向间充质细胞转化的影响
Zhonghua Yi Xue Za Zhi. 2007 Jul 17;87(27):1918-23.
10
PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.PAI-1 介导转化的人角质形成细胞中 TGF-β1+EGF 诱导的“分散”反应。
J Invest Dermatol. 2010 Sep;130(9):2179-90. doi: 10.1038/jid.2010.106. Epub 2010 Apr 29.

引用本文的文献

1
Enhancer variants on chromosome 2p14 regulating SPRED2 and ACTR2 act as a signal amplifier to protect against rheumatoid arthritis.位于 2p14 染色体上的增强子变异调控 SPRED2 和 ACTR2,作为信号放大器发挥作用,以预防类风湿关节炎。
Am J Hum Genet. 2023 Apr 6;110(4):625-637. doi: 10.1016/j.ajhg.2023.02.012. Epub 2023 Mar 15.
2
SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells.SPRED2:调控肝癌细胞上皮间质转化和干性的新分子。
Int J Mol Sci. 2023 Mar 5;24(5):4996. doi: 10.3390/ijms24054996.
3
Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial-mesenchymal transition and endothelial injury by suppressing MAPK activation.
sprouty 相关蛋白具有 EVH1 结构域 (SPRED2),通过抑制 MAPK 激活,防止高糖诱导的内皮-间质转化和内皮损伤。
Bioengineered. 2022 May;13(5):13882-13892. doi: 10.1080/21655979.2022.2086351.
4
Role of Serine Proteases at the Tumor-Stroma Interface.丝氨酸蛋白酶在肿瘤-基质界面的作用。
Front Immunol. 2022 Feb 11;13:832418. doi: 10.3389/fimmu.2022.832418. eCollection 2022.
5
Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer.MAPK的过度激活在SPRED2缺陷的ERα阳性乳腺癌中诱导他莫昔芬耐药。
Cancers (Basel). 2022 Feb 14;14(4):954. doi: 10.3390/cancers14040954.
6
Spred2 inhibits epithelial‑mesenchymal transition of colorectal cancer cells by impairing ERK signaling.Spred2 通过抑制 ERK 信号抑制结直肠癌细胞的上皮-间充质转化。
Oncol Rep. 2020 Jul;44(1):174-184. doi: 10.3892/or.2020.7586. Epub 2020 Apr 16.